Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany.

MLA

Castellsague, Jordi, et al. “Characterization of New Users of Cilostazol in the UK, Spain, Sweden, and Germany.” Pharmacoepidemiology and Drug Safety, vol. 26, no. 6, June 2017, pp. 615–24. EBSCOhost, https://doi.org/10.1002/pds.4167.

APA

Castellsague, J., Perez-Gutthann, S., Calingaert, B., Bui, C., Varas-Lorenzo, C., Arana, A., Prados-Torres, A., Poblador-Plou, B., Gonzalez-Rubio, F., Giner-Soriano, M., Roso-Llorach, A., Linder, M., Citarella, A., Scholle, O., Blenk, T., & Garbe, E. (2017). Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany. Pharmacoepidemiology and Drug Safety, 26(6), 615–624. https://doi.org/10.1002/pds.4167

Chicago

Castellsague, Jordi, Susana Perez-Gutthann, Brian Calingaert, Christine Bui, Cristina Varas-Lorenzo, Alejandro Arana, Alexandra Prados-Torres, et al. 2017. “Characterization of New Users of Cilostazol in the UK, Spain, Sweden, and Germany.” Pharmacoepidemiology and Drug Safety 26 (6): 615–24. doi:10.1002/pds.4167.